MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Genomics and Diagnostics
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,811 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,811 works in the cohort · of 4,299,418page 19 of 57

Labels cover 10 of 2,811 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,811 of 2,811 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Pervasive lesion segregation shapes cancer genome evolution
Sarah J. Aitken, Craig Anderson, Frances Connor, Oriol Pich, Vasavi Sundaram, Christine Feig +23 more
2019· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
affunlabeled
The New NCI Precision Medicine Trials
Lyndsay N. Harris, Charles D. Blanke, Harry P. Erba, James M. Ford, Robert J. Gray, Michael LeBlanc +19 more
2023· article· en· Clinical Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearchconsensus · none
12
citations
affunlabeled
Biomarker imprecision in precision medicine
Kenneth P. H. Pritzker
2018· editorial· en· Expert Review of Molecular Diagnostics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
12
citations
venueno affunlabeled
Role of Systematic Biopsy in the Era of Targeted Biopsy: A Review
Wojciech Malewski, Tomasz Milecki, Omar Tayara, Sławomir Poletajew, Piotr Kryst, Andrzej Tokarczyk +1 more
2024· review· en· Current Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
fundno affunlabeled
CAcTUS: A parallel arm, biomarker driven, phase II feasibility trial to determine the role of circulating tumor DNA in guiding a switch between targeted therapy and immune therapy in patients with advanced cutaneous melanoma.
Rebecca Lee, Dominic G. Rothwell, Shien Chow, Heather M. Shaw, Samra Turajlic, Nigel Smith +12 more
2021· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
afffundno abstractunlabeled
Targeting APOBECs in cancer: It’s about timing
Aaron N. Hata, Mani Larijani
2024· article· en· Cancer Cell· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
afffundno abstractunlabeled
Assessing Limit of Detection in Clinical Sequencing
Elizabeth Starks, Lucas Swanson, Roderick Docking, Ian Bosdet, Sarah Munro, Richard A. Moore +1 more
2021· article· en· Journal of Molecular Diagnostics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
afffundno abstractunlabeled
Ethical and Policy Issues for Seamless Phase I Oncology Trials
Nora Hutchinson, Esther Vinarov, Alexia Iasonos, Jonathan Kimmelman
2019· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearch+research_integrityconsensus · none
11
citations
affno abstractunlabeled
The European Union and personalised cancer medicine
John A. Hickman, Ian F. Tannock, Lydie Meheus, Lisa Hutchinson
2021· article· en· European Journal of Cancer· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
affaboutunlabeled
Treatment sequencing in MPC, insights from a 3˚ care center.
Ivan Barrera, Jill J. Ranger, Nooshin Roofigari, Richard Dalfen, Gerald Batist, Petr Kavan
2019· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
Loss of Genetic Information in Cancer
Webster K. Cavenee, Marc F. Hansen, Heidi Scrable, C. David James
2007· article· en· Novartis Foundation symposium· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations

How this was built: Screen · Findings · About